| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter Infections | 29 | 2020 | 1301 | 1.950 |
Why?
|
| Helicobacter pylori | 30 | 2020 | 1358 | 1.810 |
Why?
|
| Breath Tests | 24 | 2025 | 182 | 1.730 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 8 | 2018 | 39 | 1.450 |
Why?
|
| Esomeprazole | 3 | 2018 | 33 | 1.100 |
Why?
|
| Caliciviridae Infections | 14 | 2023 | 289 | 1.050 |
Why?
|
| Norwalk virus | 13 | 2015 | 115 | 0.950 |
Why?
|
| Sucrase-Isomaltase Complex | 6 | 2018 | 19 | 0.930 |
Why?
|
| Starch | 6 | 2025 | 26 | 0.880 |
Why?
|
| Digestion | 5 | 2025 | 42 | 0.870 |
Why?
|
| Gastrointestinal Agents | 3 | 2018 | 61 | 0.820 |
Why?
|
| Gastroenteritis | 11 | 2023 | 316 | 0.810 |
Why?
|
| Malabsorption Syndromes | 3 | 2020 | 29 | 0.790 |
Why?
|
| Disaccharidases | 2 | 2020 | 15 | 0.780 |
Why?
|
| Immunoenzyme Techniques | 2 | 2020 | 237 | 0.680 |
Why?
|
| Urea | 12 | 2009 | 226 | 0.650 |
Why?
|
| Amoxicillin | 4 | 2010 | 118 | 0.610 |
Why?
|
| Feces | 6 | 2023 | 725 | 0.610 |
Why?
|
| Sucrose | 3 | 2016 | 36 | 0.600 |
Why?
|
| Enzyme Therapy | 1 | 2018 | 5 | 0.580 |
Why?
|
| Antigens, Bacterial | 3 | 2020 | 320 | 0.560 |
Why?
|
| Crohn Disease | 5 | 2024 | 291 | 0.560 |
Why?
|
| Lactobacillus delbrueckii | 1 | 2018 | 2 | 0.560 |
Why?
|
| Point-of-Care Systems | 3 | 2006 | 206 | 0.550 |
Why?
|
| Norovirus | 5 | 2023 | 288 | 0.540 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 340 | 0.490 |
Why?
|
| Dietary Carbohydrates | 3 | 2012 | 108 | 0.480 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2018 | 217 | 0.470 |
Why?
|
| Anti-Bacterial Agents | 7 | 2018 | 2566 | 0.460 |
Why?
|
| Immunoglobulin G | 10 | 2015 | 810 | 0.460 |
Why?
|
| Abdominal Pain | 2 | 2012 | 314 | 0.460 |
Why?
|
| Glucose | 4 | 2020 | 847 | 0.450 |
Why?
|
| Cells | 1 | 2014 | 20 | 0.430 |
Why?
|
| Gastric Mucosa | 6 | 2006 | 489 | 0.430 |
Why?
|
| Antibodies, Viral | 10 | 2015 | 1169 | 0.420 |
Why?
|
| Cytoplasm | 1 | 2014 | 253 | 0.400 |
Why?
|
| Carbon Isotopes | 9 | 2018 | 230 | 0.390 |
Why?
|
| Intestinal Mucosa | 6 | 2019 | 764 | 0.390 |
Why?
|
| Intestine, Small | 4 | 2024 | 286 | 0.380 |
Why?
|
| Sorghum | 2 | 2025 | 9 | 0.370 |
Why?
|
| Adult | 56 | 2021 | 31628 | 0.360 |
Why?
|
| Cell Nucleus | 1 | 2014 | 567 | 0.350 |
Why?
|
| Colon | 3 | 2024 | 360 | 0.350 |
Why?
|
| Anti-Ulcer Agents | 7 | 2005 | 114 | 0.340 |
Why?
|
| Humans | 101 | 2025 | 131410 | 0.330 |
Why?
|
| Male | 72 | 2025 | 65108 | 0.320 |
Why?
|
| Middle Aged | 47 | 2020 | 28807 | 0.310 |
Why?
|
| Fasting | 2 | 2020 | 301 | 0.290 |
Why?
|
| Female | 65 | 2025 | 71030 | 0.290 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2005 | 23 | 0.280 |
Why?
|
| Antibodies, Bacterial | 5 | 2006 | 427 | 0.280 |
Why?
|
| Virus Cultivation | 2 | 2019 | 70 | 0.270 |
Why?
|
| Duodenum | 3 | 2018 | 110 | 0.270 |
Why?
|
| Prospective Studies | 13 | 2020 | 6481 | 0.270 |
Why?
|
| Anti-Infective Agents | 2 | 2006 | 265 | 0.250 |
Why?
|
| Colitis, Ulcerative | 3 | 2015 | 216 | 0.250 |
Why?
|
| Urease | 4 | 2020 | 74 | 0.240 |
Why?
|
| Fluoroquinolones | 1 | 2006 | 94 | 0.240 |
Why?
|
| Virus Replication | 4 | 2019 | 597 | 0.230 |
Why?
|
| Yogurt | 1 | 2005 | 13 | 0.230 |
Why?
|
| Brassica | 1 | 2005 | 17 | 0.230 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2142 | 0.220 |
Why?
|
| Viral Vaccines | 4 | 2015 | 317 | 0.220 |
Why?
|
| Bacteriological Techniques | 1 | 2005 | 86 | 0.220 |
Why?
|
| Growth Disorders | 1 | 2025 | 184 | 0.210 |
Why?
|
| Gastric Acidity Determination | 3 | 2004 | 24 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2010 | 426 | 0.200 |
Why?
|
| Biomarkers | 6 | 2020 | 3400 | 0.190 |
Why?
|
| Biopsy | 6 | 2020 | 1247 | 0.190 |
Why?
|
| Probiotics | 1 | 2005 | 231 | 0.190 |
Why?
|
| Energy Intake | 1 | 2025 | 501 | 0.190 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2984 | 0.190 |
Why?
|
| Aged | 19 | 2020 | 21215 | 0.180 |
Why?
|
| Immunoglobulin A | 7 | 2015 | 210 | 0.180 |
Why?
|
| Drug Therapy, Combination | 8 | 2010 | 1167 | 0.180 |
Why?
|
| Gastric Emptying | 2 | 2021 | 78 | 0.180 |
Why?
|
| Proton Pump Inhibitors | 4 | 2010 | 278 | 0.180 |
Why?
|
| Virus Shedding | 5 | 2023 | 75 | 0.170 |
Why?
|
| Celiac Disease | 2 | 2003 | 75 | 0.170 |
Why?
|
| Omeprazole | 5 | 2006 | 100 | 0.170 |
Why?
|
| Electrodes | 2 | 1991 | 81 | 0.170 |
Why?
|
| Pilot Projects | 6 | 2020 | 1450 | 0.170 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 900 | 0.160 |
Why?
|
| Gastroparesis | 1 | 2021 | 69 | 0.160 |
Why?
|
| Lactose | 2 | 2006 | 53 | 0.160 |
Why?
|
| Adolescent | 24 | 2021 | 20902 | 0.160 |
Why?
|
| Fermentation | 1 | 2020 | 67 | 0.160 |
Why?
|
| Sucrase | 2 | 2017 | 23 | 0.150 |
Why?
|
| Liver | 3 | 2017 | 1794 | 0.150 |
Why?
|
| Sialic Acids | 1 | 1999 | 17 | 0.150 |
Why?
|
| Circadian Clocks | 1 | 2020 | 86 | 0.140 |
Why?
|
| Dyspepsia | 2 | 2018 | 108 | 0.140 |
Why?
|
| Proteome | 1 | 2020 | 286 | 0.140 |
Why?
|
| Lactoferrin | 1 | 1999 | 76 | 0.140 |
Why?
|
| Millets | 1 | 2018 | 2 | 0.140 |
Why?
|
| Postprandial Period | 1 | 2018 | 86 | 0.140 |
Why?
|
| Satiety Response | 1 | 2018 | 31 | 0.140 |
Why?
|
| Rural Health | 1 | 2018 | 43 | 0.140 |
Why?
|
| Pancreatin | 1 | 1997 | 5 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 489 | 0.140 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 564 | 0.130 |
Why?
|
| Seeds | 1 | 2018 | 42 | 0.130 |
Why?
|
| Young Adult | 9 | 2020 | 10081 | 0.130 |
Why?
|
| Cystatin C | 1 | 2018 | 70 | 0.130 |
Why?
|
| Pancreas | 1 | 2018 | 218 | 0.130 |
Why?
|
| Saliva | 2 | 2015 | 137 | 0.130 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1997 | 38 | 0.130 |
Why?
|
| Stem Cells | 2 | 2019 | 712 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 360 | 0.130 |
Why?
|
| Famotidine | 2 | 2004 | 9 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1559 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 393 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2014 | 1082 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 791 | 0.120 |
Why?
|
| Liver Function Tests | 2 | 1995 | 97 | 0.120 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 165 | 0.120 |
Why?
|
| Contraceptives, Oral | 1 | 1995 | 40 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2017 | 448 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 250 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 144 | 0.110 |
Why?
|
| Vaccines, Virus-Like Particle | 1 | 2015 | 29 | 0.110 |
Why?
|
| Gastric Acid | 1 | 1995 | 55 | 0.110 |
Why?
|
| Blood Cells | 1 | 2015 | 55 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2019 | 900 | 0.110 |
Why?
|
| Antimony | 2 | 1991 | 14 | 0.110 |
Why?
|
| Clarithromycin | 4 | 2009 | 130 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 357 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 88 | 0.110 |
Why?
|
| Cross Reactions | 1 | 2014 | 187 | 0.110 |
Why?
|
| Cytosol | 1 | 2014 | 140 | 0.100 |
Why?
|
| Metabolomics | 1 | 2017 | 493 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2018 | 3448 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 39 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2013 | 80 | 0.100 |
Why?
|
| Child | 14 | 2023 | 26224 | 0.100 |
Why?
|
| Gastritis | 5 | 2004 | 372 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 365 | 0.100 |
Why?
|
| Organoids | 1 | 2016 | 307 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2012 | 266 | 0.100 |
Why?
|
| Rotavirus Infections | 1 | 2015 | 281 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 362 | 0.100 |
Why?
|
| Rotavirus | 1 | 2015 | 366 | 0.100 |
Why?
|
| Brain Death | 1 | 2013 | 74 | 0.100 |
Why?
|
| Child, Preschool | 12 | 2025 | 15037 | 0.090 |
Why?
|
| Organometallic Compounds | 5 | 2005 | 112 | 0.090 |
Why?
|
| Mali | 2 | 2025 | 12 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2011 | 9 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 833 | 0.090 |
Why?
|
| Campylobacter Infections | 5 | 1990 | 33 | 0.090 |
Why?
|
| Antigens, Viral | 2 | 2012 | 396 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 131 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2017 | 12923 | 0.090 |
Why?
|
| Siblings | 1 | 2012 | 204 | 0.090 |
Why?
|
| Cross-Over Studies | 3 | 2018 | 331 | 0.090 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 5 | 0.090 |
Why?
|
| Administration, Oral | 7 | 2017 | 705 | 0.090 |
Why?
|
| Enteral Nutrition | 1 | 2013 | 281 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2009 | 391 | 0.090 |
Why?
|
| Inflammation | 2 | 2020 | 1488 | 0.080 |
Why?
|
| Diet | 1 | 2018 | 1119 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1304 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 517 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 611 | 0.080 |
Why?
|
| Lipoproteins | 2 | 2002 | 183 | 0.080 |
Why?
|
| Time Factors | 9 | 2023 | 6272 | 0.080 |
Why?
|
| Silver Compounds | 1 | 1990 | 7 | 0.080 |
Why?
|
| Critical Illness | 1 | 1995 | 615 | 0.080 |
Why?
|
| Models, Biological | 2 | 2014 | 1390 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 57 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2007 | 231 | 0.080 |
Why?
|
| Sirolimus | 2 | 2002 | 231 | 0.080 |
Why?
|
| Cell Line | 2 | 2014 | 2604 | 0.080 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 40 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Serologic Tests | 2 | 2011 | 125 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 2 | 2018 | 154 | 0.080 |
Why?
|
| Histamine H2 Antagonists | 2 | 2004 | 49 | 0.080 |
Why?
|
| beta-Fructofuranosidase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Condiments | 1 | 1988 | 3 | 0.070 |
Why?
|
| Clinical Protocols | 2 | 2008 | 228 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1008 | 0.070 |
Why?
|
| Infant | 10 | 2025 | 13292 | 0.070 |
Why?
|
| Critical Care | 1 | 1994 | 679 | 0.070 |
Why?
|
| Ranitidine | 2 | 2005 | 30 | 0.070 |
Why?
|
| Drug Administration Schedule | 3 | 2006 | 741 | 0.070 |
Why?
|
| Citric Acid | 2 | 2005 | 45 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 894 | 0.070 |
Why?
|
| Apolipoproteins B | 2 | 2001 | 140 | 0.070 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 572 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 323 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2005 | 785 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2002 | 667 | 0.070 |
Why?
|
| alpha-Glucosidases | 1 | 2007 | 31 | 0.070 |
Why?
|
| Metronidazole | 4 | 2005 | 161 | 0.070 |
Why?
|
| Capsule Endoscopy | 1 | 2007 | 20 | 0.060 |
Why?
|
| Jejunum | 1 | 2007 | 124 | 0.060 |
Why?
|
| Galactosemias | 1 | 2006 | 14 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 566 | 0.060 |
Why?
|
| Galactose | 1 | 2006 | 53 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1945 | 0.060 |
Why?
|
| Pepsinogen C | 1 | 2006 | 10 | 0.060 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2006 | 52 | 0.060 |
Why?
|
| Pepsinogen A | 1 | 2006 | 17 | 0.060 |
Why?
|
| United States | 6 | 2010 | 11784 | 0.060 |
Why?
|
| Cholesterol | 2 | 2002 | 541 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 88 | 0.060 |
Why?
|
| Malates | 1 | 2005 | 8 | 0.060 |
Why?
|
| Gastrins | 3 | 2006 | 30 | 0.060 |
Why?
|
| Acetazolamide | 1 | 2005 | 27 | 0.060 |
Why?
|
| Freezing | 1 | 2005 | 26 | 0.060 |
Why?
|
| Mucus | 1 | 2005 | 38 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2005 | 71 | 0.060 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2005 | 27 | 0.060 |
Why?
|
| Antacids | 1 | 2005 | 28 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 38 | 0.060 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2004 | 6 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2006 | 157 | 0.050 |
Why?
|
| Ulcer | 1 | 2005 | 51 | 0.050 |
Why?
|
| Stomach Diseases | 1 | 2005 | 55 | 0.050 |
Why?
|
| Bismuth | 4 | 2000 | 84 | 0.050 |
Why?
|
| Culture Media | 1 | 2005 | 175 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 68 | 0.050 |
Why?
|
| Temperature | 1 | 2005 | 294 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2005 | 149 | 0.050 |
Why?
|
| Placebos | 2 | 2015 | 227 | 0.050 |
Why?
|
| Water Microbiology | 2 | 1996 | 28 | 0.050 |
Why?
|
| Water Supply | 2 | 1996 | 26 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 199 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 302 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2025 | 170 | 0.050 |
Why?
|
| Random Allocation | 3 | 2017 | 421 | 0.050 |
Why?
|
| Foreign-Body Migration | 1 | 2004 | 58 | 0.050 |
Why?
|
| Pentosyltransferases | 1 | 2023 | 18 | 0.050 |
Why?
|
| Diacylglycerol Kinase | 1 | 2023 | 17 | 0.050 |
Why?
|
| Kinetics | 2 | 2023 | 1101 | 0.050 |
Why?
|
| Granuloma | 1 | 2023 | 63 | 0.050 |
Why?
|
| Bacterial Vaccines | 3 | 2004 | 104 | 0.050 |
Why?
|
| Gastroscopy | 3 | 2006 | 97 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 1995 | 262 | 0.050 |
Why?
|
| Intussusception | 1 | 2003 | 54 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 3411 | 0.050 |
Why?
|
| Office Visits | 1 | 2002 | 81 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 114 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 529 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 225 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 306 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2014 | 4666 | 0.040 |
Why?
|
| Virion | 2 | 1999 | 116 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 119 | 0.040 |
Why?
|
| Peptic Ulcer | 2 | 1995 | 148 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 83 | 0.040 |
Why?
|
| Salicylates | 4 | 2000 | 54 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2000 | 38 | 0.040 |
Why?
|
| Sex Factors | 2 | 2018 | 1343 | 0.040 |
Why?
|
| Age Factors | 3 | 2000 | 2869 | 0.040 |
Why?
|
| Furazolidone | 1 | 2000 | 8 | 0.040 |
Why?
|
| Duodenal Ulcer | 2 | 1991 | 126 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2000 | 167 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 333 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1633 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2000 | 1624 | 0.040 |
Why?
|
| Tetracycline | 4 | 2005 | 75 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2000 | 75 | 0.040 |
Why?
|
| Triglycerides | 1 | 2002 | 605 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 157 | 0.040 |
Why?
|
| Immune System | 1 | 2020 | 98 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 207 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 131 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 167 | 0.040 |
Why?
|
| Colostrum | 1 | 1999 | 58 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 1999 | 190 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 2000 | 321 | 0.040 |
Why?
|
| Food | 2 | 1990 | 125 | 0.040 |
Why?
|
| Mutation | 1 | 2012 | 6177 | 0.040 |
Why?
|
| Immunity, Mucosal | 2 | 2014 | 90 | 0.040 |
Why?
|
| Creatinine | 2 | 2018 | 399 | 0.040 |
Why?
|
| Plant Tubers | 1 | 2018 | 1 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 286 | 0.030 |
Why?
|
| Solanum tuberosum | 1 | 2018 | 12 | 0.030 |
Why?
|
| Triticum | 1 | 2018 | 29 | 0.030 |
Why?
|
| Oryza | 1 | 2018 | 31 | 0.030 |
Why?
|
| Urban Health | 1 | 2018 | 85 | 0.030 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 521 | 0.030 |
Why?
|
| Texas | 2 | 2010 | 3614 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2013 | 773 | 0.030 |
Why?
|
| Lipase | 1 | 1997 | 88 | 0.030 |
Why?
|
| Acute Disease | 1 | 2000 | 1152 | 0.030 |
Why?
|
| Food Preferences | 1 | 2018 | 114 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 258 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2000 | 896 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1997 | 241 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 371 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 1995 | 547 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 44 | 0.030 |
Why?
|
| Patient Compliance | 3 | 2006 | 469 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 562 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 332 | 0.030 |
Why?
|
| Escherichia coli Infections | 2 | 1988 | 198 | 0.030 |
Why?
|
| Enterocytes | 1 | 2016 | 68 | 0.030 |
Why?
|
| Diarrhea | 2 | 1988 | 311 | 0.030 |
Why?
|
| Animals | 5 | 2020 | 34321 | 0.030 |
Why?
|
| Aminopyrine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17628 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 804 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 1995 | 37 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 604 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 1312 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 275 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 1999 | 389 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 37 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2856 | 0.030 |
Why?
|
| Paper | 1 | 1994 | 7 | 0.030 |
Why?
|
| Risk Factors | 3 | 2000 | 10947 | 0.030 |
Why?
|
| Carbon Dioxide | 3 | 2009 | 272 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 226 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 842 | 0.030 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1994 | 52 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 128 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1994 | 93 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2004 | 846 | 0.030 |
Why?
|
| False Negative Reactions | 2 | 2004 | 88 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 1993 | 48 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 4516 | 0.020 |
Why?
|
| Infant Food | 1 | 1993 | 73 | 0.020 |
Why?
|
| Lysine | 1 | 1994 | 175 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 170 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1990 | 235 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2017 | 1102 | 0.020 |
Why?
|
| Leucine | 1 | 1994 | 262 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2012 | 32 | 0.020 |
Why?
|
| Campylobacter | 2 | 1989 | 20 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1994 | 215 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 363 | 0.020 |
Why?
|
| Immunoassay | 1 | 2012 | 133 | 0.020 |
Why?
|
| Fathers | 1 | 2012 | 71 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1994 | 369 | 0.020 |
Why?
|
| Nitrofurantoin | 1 | 1991 | 10 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2011 | 112 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2011 | 130 | 0.020 |
Why?
|
| Graft Survival | 1 | 2013 | 465 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2012 | 90 | 0.020 |
Why?
|
| Bombesin | 1 | 1991 | 4 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 125 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 550 | 0.020 |
Why?
|
| Hospitalization | 1 | 1999 | 1933 | 0.020 |
Why?
|
| Buffers | 1 | 1990 | 29 | 0.020 |
Why?
|
| Glass | 1 | 1990 | 10 | 0.020 |
Why?
|
| Silver | 1 | 1990 | 27 | 0.020 |
Why?
|
| Milk, Human | 1 | 1993 | 317 | 0.020 |
Why?
|
| Calibration | 1 | 1990 | 95 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 108 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1500 | 0.020 |
Why?
|
| Taiwan | 1 | 2009 | 63 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2010 | 142 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1024 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 2783 | 0.020 |
Why?
|
| Mice | 3 | 2020 | 18464 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1990 | 297 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1907 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3087 | 0.020 |
Why?
|
| Mexico | 2 | 2006 | 198 | 0.020 |
Why?
|
| Capsaicin | 1 | 1988 | 19 | 0.020 |
Why?
|
| Fimbriae Proteins | 1 | 1988 | 20 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 746 | 0.020 |
Why?
|
| Computer Systems | 1 | 1988 | 36 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1129 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2013 | 783 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2656 | 0.020 |
Why?
|
| Apolipoprotein B-100 | 2 | 2001 | 36 | 0.020 |
Why?
|
| Equipment Design | 1 | 1990 | 553 | 0.020 |
Why?
|
| Colicins | 1 | 1988 | 4 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 222 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1162 | 0.020 |
Why?
|
| Isomaltose | 1 | 2007 | 1 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 1988 | 65 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 609 | 0.020 |
Why?
|
| Acarbose | 1 | 2007 | 7 | 0.020 |
Why?
|
| Maltose | 1 | 2007 | 16 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 282 | 0.020 |
Why?
|
| Aspirin | 1 | 1988 | 216 | 0.020 |
Why?
|
| Esophagus | 1 | 1989 | 237 | 0.020 |
Why?
|
| Galactitol | 1 | 2006 | 2 | 0.020 |
Why?
|
| Galactosephosphates | 1 | 2006 | 3 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2354 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 513 | 0.020 |
Why?
|
| Pepsinogens | 1 | 2006 | 7 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 240 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 1988 | 311 | 0.020 |
Why?
|
| Rabeprazole | 1 | 2006 | 6 | 0.020 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2006 | 30 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1988 | 492 | 0.020 |
Why?
|
| Pain | 1 | 1989 | 439 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 142 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 155 | 0.010 |
Why?
|
| Family Health | 1 | 2006 | 250 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1989 | 326 | 0.010 |
Why?
|
| Premedication | 1 | 1985 | 39 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1988 | 984 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 245 | 0.010 |
Why?
|
| Stomach | 2 | 2003 | 271 | 0.010 |
Why?
|
| Atrophy | 1 | 2006 | 251 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 5119 | 0.010 |
Why?
|
| Capsules | 1 | 2005 | 21 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2010 | 8584 | 0.010 |
Why?
|
| Tablets | 1 | 2005 | 38 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 352 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 1488 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 1839 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 1985 | 85 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 213 | 0.010 |
Why?
|
| Arthritis | 1 | 2005 | 85 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 464 | 0.010 |
Why?
|
| Peru | 2 | 1996 | 56 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 271 | 0.010 |
Why?
|
| Interleukins | 1 | 2004 | 121 | 0.010 |
Why?
|
| Sodium Bicarbonate | 1 | 2004 | 55 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6911 | 0.010 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1985 | 135 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 68 | 0.010 |
Why?
|
| Video Recording | 1 | 2005 | 207 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 1018 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 680 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 432 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1994 | 954 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 3340 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 2001 | 53 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2000 | 49 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 93 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2000 | 79 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2000 | 156 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 188 | 0.010 |
Why?
|
| Polyomavirus | 1 | 1999 | 30 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 196 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2000 | 249 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3860 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 451 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 357 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 426 | 0.010 |
Why?
|
| China | 2 | 1988 | 287 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 3833 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 1996 | 11 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 28 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 1996 | 29 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1996 | 58 | 0.010 |
Why?
|
| Adhesins, Bacterial | 1 | 1996 | 71 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1996 | 299 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1996 | 217 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 5267 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 386 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1994 | 68 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 1745 | 0.010 |
Why?
|
| Nitrogen | 1 | 1994 | 122 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1993 | 102 | 0.010 |
Why?
|
| Deuterium | 1 | 1993 | 95 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 785 | 0.010 |
Why?
|
| Potassium | 1 | 1994 | 270 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1994 | 442 | 0.010 |
Why?
|
| Veterans | 1 | 2004 | 1794 | 0.010 |
Why?
|
| Breast Feeding | 1 | 1993 | 233 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 3613 | 0.010 |
Why?
|
| Housing | 1 | 1991 | 72 | 0.010 |
Why?
|
| Amino Acids | 1 | 1994 | 620 | 0.010 |
Why?
|
| Social Class | 1 | 1991 | 210 | 0.000 |
Why?
|
| Sensory Thresholds | 1 | 1989 | 32 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1989 | 88 | 0.000 |
Why?
|
| Enterotoxins | 1 | 1988 | 77 | 0.000 |
Why?
|
| Vaccines, Inactivated | 1 | 1988 | 149 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1991 | 1235 | 0.000 |
Why?
|
| Bacterial Toxins | 1 | 1988 | 171 | 0.000 |
Why?
|
| Pyloric Antrum | 1 | 1987 | 63 | 0.000 |
Why?
|
| India | 1 | 1988 | 245 | 0.000 |
Why?
|
| Benzalkonium Compounds | 1 | 1985 | 4 | 0.000 |
Why?
|
| para-Aminobenzoates | 1 | 1985 | 4 | 0.000 |
Why?
|
| Cetrimonium Compounds | 1 | 1985 | 4 | 0.000 |
Why?
|
| Gastroscopes | 1 | 1985 | 7 | 0.000 |
Why?
|
| Benzocaine | 1 | 1985 | 5 | 0.000 |
Why?
|
| Solutions | 1 | 1985 | 53 | 0.000 |
Why?
|
| Tetracaine | 1 | 1985 | 11 | 0.000 |
Why?
|
| Mouthwashes | 1 | 1985 | 10 | 0.000 |
Why?
|
| Taste | 1 | 1985 | 28 | 0.000 |
Why?
|
| Aerosols | 1 | 1985 | 60 | 0.000 |
Why?
|
| Lidocaine | 1 | 1985 | 41 | 0.000 |
Why?
|
| Fiber Optic Technology | 1 | 1985 | 45 | 0.000 |
Why?
|
| Intestines | 1 | 1988 | 589 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1985 | 277 | 0.000 |
Why?
|
| Prevalence | 1 | 1991 | 2692 | 0.000 |
Why?
|
| Vaccination | 1 | 1988 | 1040 | 0.000 |
Why?
|